NRG Oncology Network Group Operations Center

会员网站核心摘要 NRG肿瘤学（NRG）已建立了一个庞大而多样化的成员，其中包括220个第1层 (Main成员）和1188家2级入组研究中心。NRG主要成员和附属机构位于 包括华盛顿和波多黎各。加拿大有16个主要成员国， 12个非北美主要成员分布在8个国家。NRG肿瘤学拥有最大的 NCI国家临床试验网络（NCTN）和NRG中团体的成员基础 成员也为NCTN贡献了最高比例的患者。年期间 2014年3月1日至2017年8月31日，NRG试验累积加其他NCTN组累积 由NRG成员记入的试验约占NCTN总数的三分之一 在此期间，应计费用。在这期间，9,000名参加NRG试验的美国患者中， 在同一时期，12.7%的人自认为是非洲裔，8.0%的人是西班牙裔或拉丁裔，1.3%的人自认为是非洲裔。 作为夏威夷原住民，其他太平洋岛民，美洲原住民或阿拉斯加原住民。NRG有 制定了一项审计计划，该计划符合NCI制定的指导方针， 临床试验监查分支（CTMB）。此外，NRG仔细评估方案应计费用 和数据质量，这一做法使小组能够确定和干预， 表现不佳的中心被确定。NRG开发了各种应计增强 努力包括：NRG协议支持委员会，审查所有拟议的协议 关于护理和非护理事项; NRG健康差异委员会， 主要目的是增加NRG试验中代表性不足人群的入组; 通信委员会，向NRG成员和公众提供最新信息 促进NRG活动和试验;放射肿瘤学创新中心（CIRO） 它帮助NRG成员进行放射治疗和成像质量保证过程， 包括临床试验机构资质、资格认证和病例审查;以及免费800热线 供NRG成员获取方案相关问题的答案。NRG癌症疾病部位 委员会已经为罕见肿瘤患者制定了成功的计划， 提供机会招募青少年和年轻成人患者。

Member Site Core Abstract NRG Oncology (NRG) has established a large and diverse membership that includes 220 Tier 1 (Main Members) and 1188 Tier 2 enrolling sites. NRG Main Members and affiliates are located in all 50 states, Washington, DC, and Puerto Rico. There are 16 Canadian Main Members and 12 Non-North American Main Members located in 8 countries. NRG Oncology has the largest membership base of the groups in the NCI National Clinical Trials Network (NCTN), and NRG members also contribute the highest percentage of patients to the NCTN. For the period of March 1, 2014, through August 31, 2017, NRG trial accrual plus accrual to other NCTN group trials credited to NRG by its members represents approximately a third of the total NCTN accrual for that grant period. Of the 9,000 American patients enrolled on NRG trials during this time period, 12.7% self-identified as of African descent, 8.0% as Hispanic or Latino, and 1.3% as Native Hawaiian, other Pacific Islander, Native American, or Alaska native.. NRG has developed an audit program which is in compliance with the guidelines established by the NCI's Clinical Trials Monitoring Branch (CTMB). In addition, NRG carefully evaluates protocol accrual and data quality, a practice which enables the group to identify and intervene when underperforming centers are identified. NRG has developed a variety of accrual enhancement efforts including: the NRG Protocol Support Committee that reviews all proposed protocols relative to nursing and non-nursing matters; the NRG Health Disparities Committee whose primary aim is to increase enrollment of underrepresented populations to NRG trials; the Communications Committee which provides updates to the NRG members and general public promoting NRG activities and trials; the Center for Innovation in Radiation Oncology (CIRO) which assists NRG members with radiotherapy and imaging quality assurance process, including site qualification, credentialing and case reviews; and a Toll-Free 800 Line available for NRG members to obtain answers to protocol related questions. NRG cancer disease site committees have developed successful programs for patients with rare tumors and trials that provide an opportunity to enroll adolescent and young adult patients.